Touchpoint Wipes Fragrance Free Sanitizing Wipes
Benzalkonium Chloride
Innocore Sales & Marketing Inc
Human Otc Drug
NDC 70924-002Touchpoint Wipes Fragrance Free Sanitizing Wipes also known as Benzalkonium Chloride is a human otc drug labeled by 'Innocore Sales & Marketing Inc'. National Drug Code (NDC) number for Touchpoint Wipes Fragrance Free Sanitizing Wipes is 70924-002. This drug is available in dosage form of Cloth. The names of the active, medicinal ingredients in Touchpoint Wipes Fragrance Free Sanitizing Wipes drug includes Benzalkonium Chloride - 1.3 mg/1 . The currest status of Touchpoint Wipes Fragrance Free Sanitizing Wipes drug is Active.
Drug Information:
| Drug NDC: | 70924-002 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Touchpoint Wipes Fragrance Free Sanitizing Wipes |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Proprietary Name Base: | Touchpoint Wipes Fragrance Free |
| The base of the Brand/Proprietary name excluding its suffix. |
| Proprietary Name Suffix: | Sanitizing Wipes |
| A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Benzalkonium Chloride |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Innocore Sales & Marketing Inc |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Cloth |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | BENZALKONIUM CHLORIDE - 1.3 mg/1
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | CUTANEOUS
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 09 Sep, 2016 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 11 Jun, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part333E |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Innocore Sales & Marketing Inc
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 1038558
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | F5UM2KM3W7
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 70924-002-02 | 2 POUCH in 1 BOX (70924-002-02) / 1500 CLOTH in 1 POUCH (70924-002-01) | 09 Sep, 2016 | N/A | No |
| 70924-002-04 | 2 POUCH in 1 BOX (70924-002-04) / 1800 CLOTH in 1 POUCH (70924-002-03) | 11 Dec, 2018 | N/A | No |
| 70924-002-06 | 2 POUCH in 1 BOX (70924-002-06) / 2400 CLOTH in 1 POUCH (70924-002-05) | 11 Dec, 2018 | N/A | No |
| 70924-002-09 | 2 POUCH in 1 BOX (70924-002-09) / 400 CLOTH in 1 POUCH (70924-002-07) | 11 Dec, 2018 | N/A | No |
| 70924-002-11 | 6 CANISTER in 1 BOX (70924-002-11) / 320 CLOTH in 1 CANISTER (70924-002-10) | 11 Dec, 2018 | N/A | No |
| 70924-002-13 | 6 CANISTER in 1 BOX (70924-002-13) / 150 CLOTH in 1 CANISTER (70924-002-12) | 16 Oct, 2019 | N/A | No |
| 70924-002-15 | 2 POUCH in 1 BOX (70924-002-15) / 2200 CLOTH in 1 POUCH (70924-002-14) | 11 Nov, 2019 | N/A | No |
| 70924-002-17 | 2 POUCH in 1 BOX (70924-002-17) / 650 CLOTH in 1 POUCH (70924-002-16) | 21 Sep, 2022 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose antimicrobal
Product Elements:
Touchpoint wipes fragrance free sanitizing wipes benzalkonium chloride water propylene glycol caprylyl/capryl oligoglucoside poly(laurylglucoside)-7 phenoxyethanol benzoic acid dehydroacetic acid benzalkonium chloride benzalkonium
Indications and Usage:
Use hand sanitizer to help reduce bacteria on the skin. recommended for repeated use.
Warnings:
Warnings for external use only. when using this product do not use in or near the eyes. in case of contact, rinse eyes thoroughly in water. discontinue use if irritation and redness develop. if conditions persist for more than 72 hours, consult a physician. if swallowed get medical help or contact a poison control center immediately. keep out of reach of children.
When Using:
When using this product do not use in or near the eyes. in case of contact, rinse eyes thoroughly in water.
Dosage and Administration:
Directions wet hands thoroughly with product and allow to dry. children under 6 years of age should be supervised when using this product. be sure to use entire wipe. discard after single use.
Stop Use:
Discontinue use if irritation and redness develop. if conditions persist for more than 72 hours, consult a physician.
Package Label Principal Display Panel:
Principal display panel - 1500 wipe pouch label touch point⢠sanitizing wipes 1500 wipes ⢠8"x 6" fragrance free kills 99.99% of most common germs that may cause illness principal display panel - 1500 wipe pouch label